Blepharitis risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
| (29 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Blepharitis}} | {{Blepharitis}} | ||
{{CMG}} {{AE}} {{SaraM}} | {{CMG}}; {{AE}} {{SaraM}} | ||
==Overview== | ==Overview== | ||
Common risk factors | Common risk factors for the development of blepharitis include [[dry eye]], [[acne rosacea]], [[seborrheic dermatitis]], and [[demodex|demodicosis]]. | ||
==Risk factors== | ==Risk factors== | ||
Risk factors for the development of blepharitis include: | |||
* [[Dry eye]]<ref name="pmid3818198">{{cite journal| author=Bowman RW, Dougherty JM, McCulley JP| title=Chronic blepharitis and dry eyes. | journal=Int Ophthalmol Clin | year= 1987 | volume= 27 | issue= 1 | pages= 27-35 | pmid=3818198 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3818198 }} </ref> | |||
*[[ | * Dermatologic conditions ([[acne rosacea]], [[seborrheic dermatitis]])<ref name="pmid3156100">{{cite journal| author=McCulley JP, Dougherty JM| title=Blepharitis associated with acne rosacea and seborrheic dermatitis. | journal=Int Ophthalmol Clin | year= 1985 | volume= 25 | issue= 1 | pages= 159-72 | pmid=3156100 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3156100 }} </ref> | ||
* [[Demodex|Demodicosis]]<ref>Kemal M, Sumer Z, Toker MI, et al. The prevalence of Demodex folliculorum in blepharitis patients and the normal population. Ophthalmic Epidemiol 2005;12:287-90.</ref> | |||
* [[Isotretinoin]]<ref>McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology 1982;89:1173-80.</ref><ref>Bozkurt B, Irkec MT, Atakan N, et al. Lacrimal function and ocular complications in patients treated with systemic isotretinoin. Eur J Ophthalmol 2002;12:173-6.</ref> | |||
* [[Giant papillary conjunctivitis]]<ref>Martin NF, Rubinfeld RS, Malley JD, Manzitti V. Giant papillary conjunctivitis and meibomian gland dysfunction blepharitis. CLAO J 1992;18:165-9.</ref> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Ophthalmology]] | [[Category:Ophthalmology]] | ||
Latest revision as of 20:38, 29 July 2020
|
Blepharitis Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Blepharitis risk factors On the Web | |
|
American Roentgen Ray Society Images of Blepharitis risk factors | |
|
Risk calculators and risk factors for Blepharitis risk factors | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Overview
Common risk factors for the development of blepharitis include dry eye, acne rosacea, seborrheic dermatitis, and demodicosis.
Risk factors
Risk factors for the development of blepharitis include:
- Dry eye[1]
- Dermatologic conditions (acne rosacea, seborrheic dermatitis)[2]
- Demodicosis[3]
- Isotretinoin[4][5]
- Giant papillary conjunctivitis[6]
References
- ↑ Bowman RW, Dougherty JM, McCulley JP (1987). "Chronic blepharitis and dry eyes". Int Ophthalmol Clin. 27 (1): 27–35. PMID 3818198.
- ↑ McCulley JP, Dougherty JM (1985). "Blepharitis associated with acne rosacea and seborrheic dermatitis". Int Ophthalmol Clin. 25 (1): 159–72. PMID 3156100.
- ↑ Kemal M, Sumer Z, Toker MI, et al. The prevalence of Demodex folliculorum in blepharitis patients and the normal population. Ophthalmic Epidemiol 2005;12:287-90.
- ↑ McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology 1982;89:1173-80.
- ↑ Bozkurt B, Irkec MT, Atakan N, et al. Lacrimal function and ocular complications in patients treated with systemic isotretinoin. Eur J Ophthalmol 2002;12:173-6.
- ↑ Martin NF, Rubinfeld RS, Malley JD, Manzitti V. Giant papillary conjunctivitis and meibomian gland dysfunction blepharitis. CLAO J 1992;18:165-9.